RJRohan Jha

Rohan Jha

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rohan Jha has a total of 88 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Integrating uncertainty and practice variability for epilepsy prognostication after intracranial EEG : A meta‐analysis

    by Madeline Evans, Hamza Khoudari, Steven Tobochnik, Jorge G. Burneo, John D. Rolston, Rohan Jha, Rachel J. Smith, Arie Nakhmani, Jane B. Allendorfer, Jerzy P. Szaflarski, et al.

    Objective: Intracranial electroencephalography (iEEG) practices and diagnostic testing vary among institutions, limiting standardization and optimization of surgical outcomes. This study estimates resection rates and surgical outcome effect sizes after iEEG and develops individual patient‐level data (IPD) models using the missing‐indicator method to approximate real‐world clinical uncertainties and practice variability in iEEG and surgical decision‐making. Methods: Databases were queried for studies reporting ≥12‐month outcomes after epilepsy surgery in patients with drug‐resistant epilepsy (DRE) who underwent iEEG. Random‐effects meta‐analysis estimated pooled outcome proportions. IPD analysis was performed using multivariable generalized linear regression and logistic regression models with cross‐validation and calibration assessment. Missing values for key predictors were retained as a “not specified” category to evaluate the impact of incorporating uncertainty in common clinical data on outcome prediction. Results: Primary outcomes were seizure freedom (Engel class IA or International League Against Epilepsy [ILAE] 1) and favorable seizure outcomes (Engel I or ILAE 1–2). Of 4975 studies identified, 115 met the inclusion criteria. The pooled frequency of patients undergoing resection after iEEG was 67% (95% confidence interval [CI] 60%–74%), 52% achieved seizure freedom (95% CI 48%–56%), and 58% achieved a favorable outcome (95% CI 54%–62%). IPD analysis included 1305 patients from 29 studies and identified a lesional magnetic resonance imaging (MRI; odds ratio [OR] 1.94, CI 1.48–2.55, p < .0001) and a cortical malformation (OR 1.47, CI 1.08–2.00, p = .01) as independent predictors of a favorable outcome, whereas iEEG implantation strategy (bilateral implantation OR .61, 95% CI .42–.89, p = .01) was an independent predictor of a less favorable outcome. Significance: About two‐thirds of patients undergoing iEEG proceeded to resection, and about half achieved seizure freedom. Multivariable models incorporating clinical uncertainty and practice variability were well calibrated. However, modest discrimination suggests that routinely available clinical variables alone have limited ability to predict individual surgical outcomes. More standardized and granular clinical and practice‐related data may improve individualized prognostication after iEEG.

  • Open Access

    Predicting therapeutic clinical trial enrollment for adult patients with low- and high-grade glioma using supervised machine learning

    by Mulki Mehari, Gayathri Warrier, Abraham Dada, Aymen Kabir, Aden P. Haskell-Mendoza, Arushi Tripathy, Rohan Jha, Edwin Nieblas-Bedolla, Joshua D. Jackson, Ariel T. Gonzalez, et al.

    Therapeutic clinical trial enrollment does not match glioma incidence across demographics. Traditional statistical methods have identified independent predictors of trial enrollment; however, our understanding of the interactions between these factors remains limited. To test the interactive effects of demographic, socioeconomic, and oncologic variables on trial enrollment, we designed boosted neural networks (BNNs) for all glioma patients ( n = 1042), women ( n = 445, 42.7%), and minorities ( n = 151, 14.5%) and externally validated these models [whole cohort, n = 230; women, n = 89 (38.7%); minority, n = 66 (28.7%)]. For the whole-cohort BNN, the most influential variables on enrollment were oncologic variables, including KPS [total effect (TE), 0.327], chemotherapy (TE, 0.326), tumor location (TE, 0.322), and seizures (TE, 0.239). The women-only BNN exhibited a similar trend. Conversely, for the minority-only BNN, socioeconomic variables [insurance status (TE, 0.213), occupation classification (TE, 0.204), and employment status (TE, 0.150)] were most influential. These results may help prioritize patient-specific initiatives to increase accrual.


  • Open Access

    Impact of Adjacent Muscular Anatomic Preservation on Proximal Junctional Kyphosis and Failure

    by Ruchit V. Patel, Joshua I. Chalif, Alexander G. Yearley, Rohan Jha, Eric J. Chalif, Hasan A. Zaidi


  • Beyond seizure freedom: Reduction in anti-seizure medication after epilepsy surgery

    by Rohan Jha, Melissa M.J. Chua, David D. Liu, R. Mark Richardson, Steven Tobochnik, John D. Rolston


  • Tremor Severity and Operative Parameters Predict Imbalance in Patients Undergoing Focused Ultrasound Thalamotomy

    by Rohan Jha, Aryan Wadhwa, Melissa M.J. Chua, G. Rees Cosgrove, John D. Rolston

    Background: Imbalance is the most commonly reported side effect following focused ultrasound (FUS) thalamotomy for essential tremor (ET). It remains unknown which patients are more likely to develop imbalance following FUS treatment.Objective: To identify preoperative and treatment‐related sonication parameters that are predictive of imbalance following FUS treatment.Methods: We retrospectively collected demographic data, preoperative Fahn‐Tolosa‐Marin Clinical Rating Scale for Tremor (FTM) scores and FUS treatment parameters in patients undergoing FUS thalamotomy for treatment of ET. The presence of imbalance was evaluated at several discrete time‐points with up to 4 years of follow‐up. Multiple machine learning classifiers were built and evaluated, aiming to maximize accuracy while minimizing feature set.Results: Of the 297 patients identified, the presence of imbalance peaked at 1 week following operation at 79%. This declined rapidly with 29% reporting imbalance at 3 months, and only 15% at 4 years. At 1 week, total preoperative FTM scores and Maximum Energy delivered in FUS could predict the presence of imbalance at 92.8% accuracy. At 3 months, the total preoperative FTM scores and maximum power delivered could predict the presence of imbalance with 90.6% accuracy. Post‐operative lesion size and extent into thalamic nuclei, internal capsule, and subthalamic regions were identified as likely key underlying drivers of these predictors.Conclusions: A machine learning model based on preoperative tremor scores and maximum energy/power delivered predicted the development of short‐term imbalance and long‐term imbalance following FUS thalamotomy.


  • Surgical Technique for Repair of Tegmen Dehiscence with Encephalocele: A Retrospective Study

    by Marcelle Altshuler, Rohan Jha, Saksham Gupta, Christopher S. Hong, Kaasinath Balagurunath, Jakob V.E. Gerstl, Yohan Song, Eduardo Corrales, Timothy R. Smith

    Tegmen dehiscence with encephalocele presents certain surgical challenges, necessitating innovative approaches to improve patient outcomes and minimize complications. Here we aim to evaluate the safety and efficacy of a novel middle cranial fossa craniotomy technique. Nineteen adult patients with radiographically confirmed tegmen dehiscence with encephalocele were included. Patients underwent a middle cranial fossa craniotomy technique for tegmen dehiscence repair, utilizing a split-thickness bone graft, pedicled pericranial flap, and hydroxyapatite for extradural repair and with an inlay graft for the intradural repair. The primary outcome measured was the major perioperative complications or need for revision surgery, while the secondary outcome measured was the resolution or improvement of preoperative symptoms associated with tegmen dehiscence. Our series encompassed tegmen dehiscence repairs in 19 patients, with an average age at surgery of 51 years (range: 24–82 years). The average follow-up time was 8.80 months (range: 0.43–27.62 months). Patients commonly presented with symptoms such as hearing loss (n = 8), otorrhea (n = 8), fullness or ear pressure (n = 6), dizziness or imbalance (n = 6), or a history of meningitis (n = 4), among others. Postoperatively, symptoms resolved completely in 42% of patients (n = 8) and partially in 58% of patients (n = 11). Notably, no patients required revision surgery or developed new dehiscence in the follow-up period. Our middle cranial fossa craniotomy technique for tegmen dehiscence with encephalocele repair demonstrated promising postoperative outcomes, with complete or partial symptom resolution in all patients and no major complications. Our findings suggest that this technique is a safe and effective approach for tegmen dehiscence repair.

  • Benign Natural Progression of Small Cavernous Carotid Aneurysms Suggests Limited Clinical Utility of Serial Longitudinal Follow-up

    by Rohan Jha, Maryann Zhao, Jack Y. Ghannam, Sarah Blitz, Joshua I. Chalif, Marcelle Altshuler, Rose Du

    BACKGROUND AND OBJECTIVES: Aneurysms in the cavernous segment of the internal carotid artery (ICA) often present in an indolent fashion with limited morbidity. However, their growth progression and possible rupture over time remains poorly defined, thereby limiting optimization of serial follow-up. Thus, we aim to describe the progression of cavernous ICA aneurysms over time, as well as the patient and aneurysm characteristics associated with possible growth and rupture status. METHODS: We identified a consecutive cohort of 157 patients from 2007 to 2021 with cavernous ICA aneurysms. Patient demographic data, possible risk factors, presenting symptoms, radiographic features of aneurysms, size progression, rupture status, and concomitant noncavernous aneurysm rupture data were manually extracted. RESULTS: One hundred and fifty-seven patients (mean age at diagnosis 57.2 ± 15.6 years; 85.4% females) with 174 cavernous carotid aneurysms (CCAs) were followed for an average of 7.1 ± 4.8 years. 76.4% of aneurysms were identified incidentally, with predominantly ocular palsies as the presenting symptoms in remaining primary cases. Most aneurysms were small, and of the 168 aneurysms that were followed, 98.2% did not demonstrate appreciable growth. Of the aneurysms that grew, it took an average of 6.0 years to grow 1.6 ± 0.2 mm. Demographic data, hypertension, and smoking status were not associated with aneurysm growth. Most radiographic features also were not associated with growth, except long-axis diameter, which had an odds ratio of 1.4 (CI: 1.2, 1.8) on multivariable analysis. Presenting clinical symptoms were not associated with growth. No CCAs ruptured during follow-up. CONCLUSION: Cavernous ICA aneurysms in our series demonstrate no rupture and limited growth over years of clinical follow-up. No radiographic or patient risk factors were associated with growth except initial aneurysm size. Hence, small CCAs may not require close follow-up over time.


  • Open Access

    Predictors of SOZ localization, subsequent surgical intervention, and seizure outcomes in iEEG

    by Rohan Jha, Melissa M. J. Chua, Rani Sarkis, Steven Tobochnik, John D. Rolston

    Objective: A third of the patients who undergo intracranial EEG (iEEG) for seizure‐onset zone (SOZ) localization do not proceed to resective surgery for epilepsy, and over half of those who do continue to have seizures following treatment. To better identify candidates who are more likely to see benefits from undergoing iEEG, we investigated preoperative and iEEG peri‐operative features associated with the localization of a putative SOZ, undergoing subsequent surgical treatment, and seizure outcomes. Methods: We conducted a retrospective cohort study of consecutive patients who underwent iEEG from 2001 to 2022 at two institutions. Outcomes included SOZ identification, proceeding to surgical treatment (resection vs. neuromodulation), and subsequent seizure freedom. Results: We identified 329 unique patients who were followed for a median of 3.9 (IQR:7) years, with a minimum of 2‐year follow‐up for seizure outcomes analyses. Multivariate analysis identified lateralized and lobar localization on scalp EEG (OR 3.8, p = 0.001) to be associated with SOZ localization. Patients with unilateral localization on scalp EEG (OR 3.0, p = 0.003), unilateral preimplantation hypothesis (OR 3.1, p = 0.001), and lesional preoperative MRI (OR 2.1, p = 0.033) were more likely to undergo resection than neuromodulation. Similarly, a unilateral pre‐implantation hypothesis (OR 2.6, p < 0.001) favored seizure freedom, whereas prior neuromodulation (OR 0.3, p = 0.013) decreased the odds. Larger number of preoperative anti‐seizure medications (ASMs) did not influence seizure freedom rates but did decrease favorable (Engel I, II) seizure outcomes (OR 0.7, p = 0.026). Interpretation: Non‐invasive localization data prior to iEEG are associated with subsequent resection and seizure freedom, independent of iEEG localization. Factors predictive of SOZ localization are not necessarily predictive of post‐operative seizure freedom.


  • Open Access

    Evaluating the Need for Durotomy and Duraplasty in Adults Undergoing Suboccipital Craniectomy for Chiari Decompression: A Case Series Analysis of Radiographic and Clinical Outcomes

    by Rohan Jha, Joshua I Chalif, Yi Lu

    Background Suboccipital craniectomy (SOC) in conjunction with dura opening and duraplasty for posterior fossa decompression is an effective treatment for symptomatic Chiari 1 malformations (CM1), primarily carried out in the pediatric population. However, dural opening and reconstruction are associated with an increased risk of complications, and their necessity in the adult population has not yet been robustly demonstrated. Given differences in clinical presentation and disease severity between the pediatric and adult patients, we aimed to identify if SOC alone with intraoperative ultrasound confirmation of adequate restoration of pulsatile motion of cerebellar tonsil is sufficient to treat symptomatic CM1 while mitigating surgical risks. Methods We identified a retrospective, institutional cohort of adult patients who underwent SOC for Chiari decompression between 2014 and 2023. Demographic, clinical, and radiographic features were extracted for each patient. Clinical outcomes were assessed using the Chicago Chiari Outcome Scale (CCOS) and MotorSensory -Sphincter signs score (Clinical Sign Score (CSS)). Radiographic outcomes assessed cerebellar ectopia and associated syrinx characteristics. Results A total of 15 patients were identified, with an average follow-up period of three years. Eight patients underwent SOC with duraplasty, whereas seven patients underwent SOC only without duraplasty. Both groups of patients were of similar age at surgery and had similar nature and duration of symptoms prior to surgery. On pre -operative radiographic evaluation, both groups of patients had similar lengths of cerebellar ectopia (9.9 +/- 11.0 mm to 11.1 +/- 5.7 mm, p=0.591), and associated syrinxes (75% vs. 42.9%, p=0.205). Intraoperatively, both groups had similar estimated blood losses, though the length of surgery was significantly shorter when durotomy was spared (202 +/- 58.3 minutes to 116.3 +/- 47.8 minutes, p=0.011). The length of ICU stay was also significantly longer in the durotomy group (1.1 +/- 0.6 days to 0.0 days, p<0.001). Neither group reported any post -operative complications. On follow-up, both groups demonstrated similar reductions in cerebellar ectopia and syrinx characteristics. Clinically, the CCOS and CSS scores were similar between the two cohorts at follow-up, with no repeat surgery required in either group. Conclusion Our cohort suggests that for adult CM1 patients, SOC decompression alone without dural reconstruction might lead to comparable clinical and radiographic outcomes to SOC decompression with durotomy/duraplasty, especially if intraoperative ultrasound confirms good cerebrospinal fluid (CSF) flow after SOC. Notably, sparing durotomy and duraplasty is also associated with decreased operative time and decreased ICU stay.